Skip to content
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics
Breast implants
Dermal reconstruction
Nevelia
Nevelia Pro
Surgical procedure
Clinical cases
Clinical data publications
Live webinars
Videos
Brochures
Black and Black Surgical
Administration systems
B2B administration systems
administration systems SD products
Therapeutics
Aesthetics ESTYME®
Aesthetic SEBBIN
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Linkedin-in
Youtube
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics ESTYME®
Aesthetic SEBBIN
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Menu
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics ESTYME®
Aesthetic SEBBIN
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
SOLUTIONS
THERAPEUTICS
Therapeutics
Dermal Reconstruction
NEVELIA®
NEVELIA® Pro
AESTHETIC ESTYME®
Aesthethics
ESTYME Dermal fillers
ESTYME Breast implants
Black and black surgical
AESTHETIC SEBBIN
Aesthethics
SEBBIN Breast implants
SEBBIN Body implants
SEBBIN Custom made implants
SEBBIN Lipofilling
Administration systems
Administration systems
B2B Administration systems
Administration system SD products
IMPACT
CSR commitments and objectives
Symatese Foundation
Symatese Charters
NEWS
View our latests news
CAREERS
View open positions
CONTACT
Get in touch
Category: Qualité & Validation
SYMATESE reaches a decisive milestone!
October 31, 2024
SYMATESE Announces Submission to U.S. FDA for its Pre-market approval Application for its HA dermal fillers
June 25, 2024
SFB: from 19 to 21 June, come and meet us on stand B1!
June 13, 2024
SYMATESE DEVICE at “The Pharma Days” in Geneva
May 6, 2024
Lacrifill®: a new dry eye treatment by Nordic Pharma
April 25, 2024
SYMATESE celebrates 10 years with NEVELIA®
April 11, 2024
